Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Safety and effectiveness of the Silimed Gel-Filled Mammary Implant as indicated for primary augmentation, primary reconstruction, and/or revision of the female breast.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Primary Augmentation | Experimental | Silimed Gel-Filled Mammary Implant |
|
| Revision-Augmentation | Experimental | Silimed Gel-Filled Mammary Implant |
|
| Primary Reconstruction | Experimental | Silimed Gel-Filled Mammary Implant |
|
| Revision-Reconstruction | Experimental | Silimed Gel-Filled Mammary Implant |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Silimed Gel-Filled Mammary Implant | Device |
|
| Measure | Description | Time Frame |
|---|---|---|
| Local Complications | Assessment of the safety of the Study Implants is based on the incidence of adverse events through 10 years. | 10 Years |
| Measure | Description | Time Frame |
|---|---|---|
| Satisfaction Determined by Patients | Assessment of the effectiveness of Study Implants based on patient satisfaction using a 5-point scale where 1=strongly agree to 5= strongly disagree. The patient satisfaction measures through 10 years provided in the table below are based on questionnaire responses of "Strongly Agree" and "Agree." | 10 Years |
Not provided
Inclusion Criteria
Subjects are admitted into the study only if all of the following eligibility is true:
Female
Age limitation specific to the indication:
Adequate tissue available to cover implant(s)
Willingness to follow study requirements (informed consent form, follow-up visits)
Candidate for primary augmentation, primary reconstruction, or revision
Exclusion Criteria
Subjects are not eligible if any of the following criteria exist:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Denise Dajles, PhD | Tiger Biosciences, LLC. | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Sientra, Inc. | Santa Barbara | California | 93117 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 23096598 | Background | Stevens WG, Harrington J, Alizadeh K, Berger L, Broadway D, Hester TR, Kress D, d'Incelli R, Kuhne J, Beckstrand M. Five-year follow-up data from the U.S. clinical trial for Sientra's U.S. Food and Drug Administration-approved Silimed(R) brand round and shaped implants with high-strength silicone gel. Plast Reconstr Surg. 2012 Nov;130(5):973-981. doi: 10.1097/PRS.0b013e31826b7d2f. | |
| 25948657 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Primary Augmentation | Silimed Gel-Filled Mammary Implant Silimed Gel-Filled Mammary Implant |
| FG001 | Revision-Augmentation | Silimed Gel-Filled Mammary Implant Silimed Gel-Filled Mammary Implant |
| FG002 | Primary Reconstruction | Silimed Gel-Filled Mammary Implant Silimed Gel-Filled Mammary Implant |
| FG003 | Revision-Reconstruction | Silimed Gel-Filled Mammary Implant Silimed Gel-Filled Mammary Implant |
| Title | Milestones | Reasons Not Completed | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
|
All enrolled subjects are included.
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Primary Augmentation | Silimed Gel-Filled Mammary Implant Silimed Gel-Filled Mammary Implant |
| BG001 | Revision-Augmentation | Silimed Gel-Filled Mammary Implant Silimed Gel-Filled Mammary Implant |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Customized | Number |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Local Complications | Assessment of the safety of the Study Implants is based on the incidence of adverse events through 10 years. | All subjects are included. | Posted | Count of Participants | Participants | 10 Years |
|
Baseline (Surgery) to 10 Years
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Primary Augmentation | Silimed Gel-Filled Mammary Implant Silimed Gel-Filled Mammary Implant |
Not provided
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Asymmetry | Surgical and medical procedures | Systematic Assessment |
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Chief Technology Officer | Sientra | (805) 562-3500 | denise.dajles@sientra.com |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Aug 11, 2008 | Dec 13, 2023 | Prot_SAP_000.pdf |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Background |
| Stevens WG, Harrington J, Alizadeh K, Broadway D, Zeidler K, Godinez TB. Eight-year follow-up data from the U.S. clinical trial for Sientra's FDA-approved round and shaped implants with high-strength cohesive silicone gel. Aesthet Surg J. 2015 May;35 Suppl 1:S3-10. doi: 10.1093/asj/sjv020. |
| 26961987 | Background | Stevens WG, Calobrace MB, Harrington J, Alizadeh K, Zeidler KR, d'Incelli RC. Nine-Year Core Study Data for Sientra's FDA-Approved Round and Shaped Implants with High-Strength Cohesive Silicone Gel. Aesthet Surg J. 2016 Apr;36(4):404-16. doi: 10.1093/asj/sjw015. |
| 29595714 | Background | Stevens WG, Calobrace MB, Alizadeh K, Zeidler KR, Harrington JL, d'Incelli RC. Ten-year Core Study Data for Sientra's Food and Drug Administration-Approved Round and Shaped Breast Implants with Cohesive Silicone Gel. Plast Reconstr Surg. 2018 Apr;141(4S Sientra Shaped and Round Cohesive Gel Implants):7S-19S. doi: 10.1097/PRS.0000000000004350. |
| Explantation of study device(s) |
|
| Subject Request |
|
| Lost to Follow-up |
|
| BG002 | Primary Reconstruction | Silimed Gel-Filled Mammary Implant Silimed Gel-Filled Mammary Implant |
| BG003 | Revision-Reconstruction | Silimed Gel-Filled Mammary Implant Silimed Gel-Filled Mammary Implant |
| BG004 | Total | Total of all reporting groups |
| participants |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Race/Ethnicity, Customized | Number | participants |
|
| Region of Enrollment | Number | participants |
|
Silimed Gel-Filled Mammary Implant Silimed Gel-Filled Mammary Implant |
| OG003 | Revision-Reconstruction | Silimed Gel-Filled Mammary Implant Silimed Gel-Filled Mammary Implant |
|
|
| Secondary | Satisfaction Determined by Patients | Assessment of the effectiveness of Study Implants based on patient satisfaction using a 5-point scale where 1=strongly agree to 5= strongly disagree. The patient satisfaction measures through 10 years provided in the table below are based on questionnaire responses of "Strongly Agree" and "Agree." | All patients that completed the Patient Satisfaction survey at Year 10. | Posted | Count of Participants | Participants | 10 Years |
|
|
|
| 10 |
| 1,116 |
| 0 |
| 1,116 |
| 360 |
| 1,116 |
| EG001 | Revision-Augmentation | Silimed Gel-Filled Mammary Implant Silimed Gel-Filled Mammary Implant | 4 | 363 | 0 | 363 | 122 | 363 |
| EG002 | Primary Reconstruction | Silimed Gel-Filled Mammary Implant Silimed Gel-Filled Mammary Implant | 15 | 225 | 0 | 225 | 100 | 225 |
| EG003 | Revision-Reconstruction | Silimed Gel-Filled Mammary Implant Silimed Gel-Filled Mammary Implant | 8 | 84 | 0 | 84 | 45 | 84 |
| Capsular Contracture(Baker Grade II) | Skin and subcutaneous tissue disorders | Systematic Assessment |
|
| Capsular Contracture (Baker Grade III/IV) | Skin and subcutaneous tissue disorders | Systematic Assessment |
|
| Implant Malposition | Surgical and medical procedures | Systematic Assessment |
|
| Infection | Infections and infestations | Systematic Assessment |
|
| Nipple Sensation Changes | Skin and subcutaneous tissue disorders | Systematic Assessment |
|
| Explantation with or without replacement | Surgical and medical procedures | Systematic Assessment |
|
Not provided
Not provided
| Patient thinks her breast implants make her look normal. |
|
| Patient thinks her breast implants make her feel more feminine. |
|
| Patient thinks her breast implants make her feel more sensual. |
|
| Patient thinks her breast implants make her clothes feel better. |
|
| Patient thinks her breast implants make her feel more attractive. |
|
| Patient thinks her breast implants make her feel better about herself. |
|
| Patient thinks her breast implants improve her family life. |
|
| Patient thinks her breast implants improve her social life. |
|
| Patient thinks her breast implants improve her daily relations with husband or partner. |
|
| Patient thinks her breast implants improve her sex life. |
|